In recent times, music copyrights and their ownership/rights to producers, artists, among other stakeholders, have been under strong discussion across geographies. We are happy to have a written piece by Gemma Harrison, a freelance writer, on her high-level take on…
Controller General of Patents, Design and Trade Marks, Mr. Chaitanya Prasad, has issued a Public Notice on 1 January 2015, wherein it has been put forth that, from December 31, 2014, Official Fees for filing a new Design application as…
In the recent decision of Delhi High Court in the case of Reckitt Benckiser(India) Ltd v Dabur India Ltd, the Hon’ble court decided on the issue of deceptive similarity between the television advertisement of Pudin Hara lemon fizz drink and…
We are very glad to announce Khurana & Khurana, Advocate and IP Attorneys (K&K) 's acquisition of Closer2Patents, a growing IP Consulting Practice based in Mumbai, effective 1'st Jan 2015. With a practice currently spread across three offices, Delhi, Pune,…
This article is related to a recent judgment of the Intellectual Property Appellate Board (hereinafter IPAB) dated 4th December 2014 in the case “E.I.DU Pont De Nemours & Company V. Galpha Laboratories and Ors.” Brief Facts: On 11th March 2009,…
Reportedly, a bench of Delhi High Court temporarily allowed Xiaomi to sell a few of its devices in India about a week after the suspension of its sales in the third-largest smartphone market of the world. Xiaomi as well as…
The applicant, in this case, is M/s Air Master Equipments India (P) Ltd and Respondents are: Mr Ramesh Nana Mhatre, who is the inventor and Applicant of the granted patent application being discussed, and Controller of Patents who granted the…
In the latest update, Novartis has sued Cipla for infringing its patents on “Onbrez” (Indacaterol) after Cipla launched its generic version for Indacaterol in October claiming “urgent unmet need” for the drug in India. Earlier, as we have reported here,…
As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s…
In CS(OS) 3775/2014, as we understand from multiple sources, Xiaomi has been injuncted from manufacturing its line of smartphones for it has been prima-facie found to be infringing on certain standard-essential patents of Ericsson. Although the order is not uploaded…